Pages that link to "Q3857106"
Jump to navigation
Jump to search
The following pages link to chronic idiopathic myelofibrosis (Q3857106):
Displaying 50 items.
- cellular phase chronic idiopathic myelofibrosis (Q18557834) (← links)
- CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis (Q24649607) (← links)
- Bone marrow fibrosis in primary myelofibrosis: pathogenic mechanisms and the role of TGF-β (Q26745943) (← links)
- Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary Myelofibrosis (Q26774212) (← links)
- CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients (Q27852820) (← links)
- Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations (Q27853374) (← links)
- The Thr224Asn mutation in the VPS45 gene is associated with the congenital neutropenia and primary myelofibrosis of infancy (Q28289219) (← links)
- Rescue of a primary myelofibrosis model by retinoid-antagonist therapy (Q30557756) (← links)
- A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells. (Q31110460) (← links)
- Allogeneic bone marrow transplantation for primary myelofibrosis (Q33197751) (← links)
- Chronic idiopathic myelofibrosis: clinicopathologic features, pathogenesis, and prognosis (Q33252344) (← links)
- Dynamics of bone marrow changes in patients with chronic idiopathic myelofibrosis following allogeneic stem cell transplantation (Q33366694) (← links)
- Expression profiling of apoptosis-related genes in megakaryocytes: BNIP3 is downregulated in primary myelofibrosis (Q33374192) (← links)
- Reappearance of t(12;17)-positive primary myelofibrosis following Ph+ CML cell reduction by imatinib (Q33375897) (← links)
- New and old treatment modalities in primary myelofibrosis (Q33377528) (← links)
- Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele (Q33385124) (← links)
- Beneficial treatment with methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in a patient with primary myelofibrosis (Q33388685) (← links)
- Identification during the follow-up of time-dependent prognostic factors for the competing risks of death and blast phase in primary myelofibrosis: a study of 172 patients (Q33388851) (← links)
- Comparison of different criteria for the diagnosis of primary myelofibrosis reveals limited clinical utility for measurement of serum lactate dehydrogenase (Q33390032) (← links)
- Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients (Q33392291) (← links)
- DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status (Q33393245) (← links)
- Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study (Q33394025) (← links)
- Reversal of transfusion dependence by tumor necrosis factor inhibitor treatment in a patient with concurrent rheumatoid arthritis and primary myelofibrosis (Q33395526) (← links)
- Successful high-dose methylprednisolone therapy in a patient with primary myelofibrosis (Q33396213) (← links)
- A phase I study of panobinostat (LBH589) in patients with primary myelofibrosis (PMF) and post-polycythaemia vera/essential thrombocythaemia myelofibrosis (post-PV/ET MF). (Q33405372) (← links)
- Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polycythaemia vera myelofibrosis (Q33407924) (← links)
- Metastatic splenic angiosarcoma presenting with thrombocytopenia and bone marrow fibrosis mimicking idiopathic thrombocytopenic purpura and primary myelofibrosis: a diagnostic challenge (Q33408634) (← links)
- Ruxolitinib for the treatment of primary myelofibrosis (Q33413637) (← links)
- Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis (Q33416223) (← links)
- Acute respiratory distress syndrome in a patient with primary myelofibrosis after ruxolitinib treatment discontinuation (Q33416494) (← links)
- X-linked thrombocytopenia with thalassemia displays bone marrow reticulin fibrosis and enhanced angiogenesis: comparisons with primary myelofibrosis (Q33418847) (← links)
- Correlation of JAK2V617F mutational status in primary myelofibrosis with clinico-hematologic characteristics and international prognostic scoring system scoring: a single center experience (Q33422099) (← links)
- Improvement of Anaemia in Patients with Primary Myelofibrosis by Low-Dose Thalidomide and Prednisone (Q33434654) (← links)
- Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis (Q33442613) (← links)
- Prognostic significance of a comprehensive histologic evaluation of reticulin fibrosis, collagen deposition and osteosclerosis in primary myelofibrosis patients (Q33443649) (← links)
- Transient promyelocytic expansion in primary myelofibrosis (Q33488409) (← links)
- Hematological remission of primary myelofibrosis with antiphospholipid antibody following treatment of azathioprine (Q33489436) (← links)
- Plasma soluble interleukin-2 receptor in patients with primary myelofibrosis (Q33492800) (← links)
- 1 alpha-Hydroxyvitamin D3 in the treatment of primary myelofibrosis: in vitro effect of vitamin D3 metabolites on the bone marrow fibroblasts. (Q33494033) (← links)
- MicroRNA expression profiling of megakaryocytes in primary myelofibrosis and essential thrombocythemia (Q33509139) (← links)
- Mature survival data for 176 patients younger than 60 years with primary myelofibrosis diagnosed between 1976 and 2005: evidence for survival gains in recent years (Q33517074) (← links)
- Case of bilateral retinal neovascularization associated with chronic idiopathic myelofibrosis (Q33551185) (← links)
- Allogeneic transplantation for primary myelofibrosis with BM, peripheral blood or umbilical cord blood: an analysis of the JSHCT (Q33556843) (← links)
- Comparison of the Mutational Profiles of Primary Myelofibrosis, Polycythemia Vera, and Essential Thrombocytosis (Q33595912) (← links)
- Thrombospondin-1 (TSP-1) in primary myelofibrosis (PMF) - a megakaryocyte-derived biomarker which largely discriminates PMF from essential thrombocythemia (Q33631390) (← links)
- F-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Appearance of Extramedullary Hematopoesis in a Case of Primary Myelofibrosis (Q33711600) (← links)
- Pathological interactions between hematopoietic stem cells and their niche revealed by mouse models of primary myelofibrosis (Q33753094) (← links)
- SNPs array karyotyping reveals a novel recurrent 20p13 amplification in primary myelofibrosis (Q34081581) (← links)
- Intestinal obstruction caused by extramedullary hematopoiesis and ascites in primary myelofibrosis (Q34137469) (← links)
- Evidence that prefibrotic myelofibrosis is aligned along a clinical and biological continuum featuring primary myelofibrosis (Q34247430) (← links)